|
|
|
News for Food and Drug Administration (FDA)News > FDAListings 61 - 70 of 441:
FDA Issues Second Safety Warning on Fentanyl Skin Patch
The Food and Drug Administration today issued its second safety warning about the fentanyl transdermal system, an adhesive patch that delivers a poten...
FDA Warns About Potential for Botulism in Canned Green Beans
The U.S. Food and Drug Administration (FDA) is warning consumers about a potential Clostridium botulinum (C. botulinum) contamination of canned cut gr...
FDA Approves ATS Medical's AP360 Mechanical Heart Valve
ATS Medical, manufacturer and marketer of state-of-the-art cardiac surgery products and services, today announced U.S. Food and Drug Administration (F...
FDA Approves Bystolic, a Novel Beta Blocker
Forest Laboratories and Mylan announced that the novel beta blocker Bystolic (nebivolol) was approved by the U.S. Food and Drug Administration (FDA) f...
FDA and Pharsight Continue to Collaborate Under CRADA
Pharsight Corporation, provider of software, strategic consulting, and regulatory services for optimizing clinical drug development, today provided an...
FDA Reviewing Potential Anti-Arrhythmic Claims for Ranexa
CV Therapeutics, announced that the U.S. Food and Drug Administration (FDA) has notified the Company that it will evaluate the approval of potential a...
FDA Launches E-mail Alert Subscription Service through Public Web site
The U.S. Food and Drug Administration today announced a new e-mail service that alerts subscribers whenever information is updated on certain FDA Web ...
FDA Okays Cymbalta for Maintenance Treatment of Major Depressive Disorder
Eli Lilly and Company announced that the U.S. Food and Drug Administration (FDA)has approved Cymbalta (duloxetine HCl) for the maintenance treatment o...
FDA Chooses Genedata Bioinformatics Platform
Genedata, provider of in silico solutions for the pharmaceutical and life sciences industries, announced an agreement with the National Center for To...
Leading U.S. Physician Criticizes Delaying FDA Sunscreen Labeling Decision For Another Month
The U.S. Food and Drug Administration on Tuesday delayed its decision on adopting a new rule and rating system for over-the-counter sunscreen products... |
|
|
Privacy Policy | Terms & Conditions | Support | Directory Links | Contact Us | Site Map | Home Copyright © 2007-2008 ComplianceHome.com. A SUPREMUS GROUP venture. All rights reserved. |